NAVB

Navidea Biopharmaceuticals Inc.

Delisted

NAVB was delisted on the 5th of October, 2023.

54 hedge funds and large institutions have $2.8M invested in Navidea Biopharmaceuticals Inc. in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
Holders Change %
0%
% of All Funds
1.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
6
Reduced
9
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
VF
26
Virtu Financial
New York
$9K +$6.5K +1,433 +260%
Bank of America
27
Bank of America
North Carolina
$8K -$671 -145 -8%
PP
28
PDS Planning
Ohio
$8K
LFG
29
LifePlan Financial Group
Ohio
$7K
Commonwealth Equity Services
30
Commonwealth Equity Services
Massachusetts
$7K
USAA
31
United Services Automobile Association
Texas
$6K
JCM
32
Jacobi Capital Management
Pennsylvania
$5K
JPMorgan Chase & Co
33
JPMorgan Chase & Co
New York
$5K +$5K +1,050 New
LA
34
Lynch & Associates
Indiana
$4K
RJA
35
Raymond James & Associates
Florida
$4K
MCG
36
McCollum Christoferson Group
New York
$4K
PNC Financial Services Group
37
PNC Financial Services Group
Pennsylvania
$3K
HC
38
Hamilton Capital
Ohio
$3K
Ameriprise
39
Ameriprise
Minnesota
$3K
SIS
40
Sound Income Strategies
Florida
$3K +$3K +599 New
CIBC World Market
41
CIBC World Market
Ontario, Canada
$2K
B
42
Bailard
California
$2K
MWPCG
43
Measured Wealth Private Client Group
New Hampshire
$2K +$2K +639 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$1K -$40 -5 -4%
CPIG
45
Chicago Partners Investment Group
Illinois
$1K
ASN
46
Advisory Services Network
Georgia
$1K
MFW
47
Mosaic Family Wealth
Missouri
$1K
AWM
48
Aevitas Wealth Management
Massachusetts
$1K
GC
49
Guggenheim Capital
Illinois
-$18K -2,510 Closed
GWM
50
Greenwich Wealth Management
Connecticut
-$15K -2,070 Closed